aspirin has been researched along with Cardiovascular Pregnancy Complications in 172 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study involved the follow-up by questionnaires and hospital records of patients with an ongoing pregnancy in a prospective, randomized, double-blind, placebo-controlled trial on the effect of low-dose aspirin during IVF." | 9.14 | Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. ( Groeneveld, E; Homburg, R; Hompes, PG; Hoozemans, DA; Lambalk, CB; Lambers, MJ; Schats, R, 2009) |
| "In the present study, the incidence of hypertensive pregnancy complications did not differ statistically significantly between low-dose aspirin and placebo groups in unselected IVF/ICSI patients, when medication was started concomitantly with gonadotrophin stimulation and continued until delivery." | 9.14 | Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study. ( Haapsamo, M; Heinonen, S; Martikainen, H; Nuojua-Huttunen, S; Räsänen, J; Tinkanen, H, 2010) |
| "The objectives of the study were to confirm the validity of using oscillometric measurement of MAP in the left lateral position to identify those at high risk for developing pregnancy-induced hypertension (PIH), and to assess and compare the efficacy of prophylaxis with low-dose aspirin or calcium supplementation in high-risk patients." | 9.09 | Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension. ( Fung, HY; Hung, CY; Rogers, MS, 1999) |
| "This study extends previous results on the effects of low-dose aspirin on blood pressure in pregnant women at differing risk of developing hypertension in pregnancy and who received aspirin at different times according to their rest-activity cycle." | 9.09 | Administration time-dependent effects of aspirin in women at differing risk for preeclampsia. ( Alonso, I; Ayala, DE; Codesido, J; Fernández, JR; Hermida, RC; Iglesías, M; Mojón, A; Silva, I; Ucieda, R, 1999) |
| "To analyze determinants of the risk of pregnancy-induced hypertension (PIH) with or without proteinuria, we compared characteristics of women enrolled in the Italian Study of Aspirin in Pregnancy who developed PIH and those who did not." | 9.08 | Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Italian Study of Aspirin in Pregnancy Group. ( Benedetto, C; Bortolus, R; Chatenoud, L; Marozio, L; Parazzini, F; Restelli, S; Ricci, E, 1996) |
| "The aims of this prospective study were to explore the changes in platelet angiotensin II (A-II) binding in pregnancy amongst Chinese women at high risk of developing pregnancy-induced hypertension (PIH) and the effects of low-dose aspirin and calcium supplementation on A-II binding." | 9.08 | Platelet angiotensin II receptor status during pregnancy in Chinese women at high-risk of developing pregnancy-induced hypertension. ( Arumanayagam, M; Hung, C; Rogers, MS, 1996) |
| "We found an association between the addition of ketanserin to aspirin and a decrease in the number of cases of pre-eclampsia and severe hypertension, as well as improved pregnancy outcome among patients with mild to moderate midtrimester hypertension." | 9.08 | Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. ( Odendaal, HJ; Steyn, DW, 1997) |
| "Forty-six nulliparous women in third trimester of pregnancy with a raised blood pressure of 30 mm Hg (systolic) or/and 15 mm Hg (diastolic) or both, over baseline values were treated with 75 mg of aspirin per day." | 9.07 | A study of use of low dose aspirin in prevention of pregnancy induced hypertension. ( Pan, S; Roy, UK, 1994) |
| "Effectiveness of early administered low-dose aspirin in prevention of pregnancy-induced hypertension (PIH) and fetal growth retardation in twin pregnancies was investigated in a randomized placebo controlled, double-blind trial in 47 twin pregnancies." | 9.07 | Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: a preliminary report. ( Arieli, S; Bukovski, I; Caspi, E; Raziel, A; Sherman, D; Weinraub, Z, 1994) |
| "To study the effect of daily treatment with 50 mg of aspirin (ASA) on the hypertensive pregnancy complications and on the production prostacyclin (PGI2) and thromboxane A2 (TxA2) in high risk pregnant women and their infants." | 9.07 | Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. ( Hartikainen-Sorri, AL; Hiilesmaa, V; Lumme, R; Viinikka, L; Ylikorkala, O, 1993) |
| "Our aim was to test the hypothesis that acetylsalicylate (aspirin) treatment reduces the incidence or severity of pregnancy-associated hypertension." | 9.07 | Low-dose aspirin therapy to prevent preeclampsia. ( Copper, RL; Cutter, GR; DuBard, MB; Goldenberg, RL; Hauth, JC; Parker, CR; Philips, JB, 1993) |
| "Low dose aspirin would appear to be an appropriate agent for the inhibition of platelet reactivity associated with hypertensive pregnancy." | 9.07 | A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension. ( Broughton Pipkin, F; Fox, S; Heptinstall, S; Louden, KA; Mitchell, JR; O'Callaghan, C; Symonds, EM; Tuohy, P, 1992) |
| "The effect of low doses of aspirin on women with mild pregnancy-induced hypertension was investigated by means of a prospective, randomized, double-blind trial." | 9.06 | Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension. ( Barkai, G; Ben-Baruch, G; Mashiach, S; Schiff, E, 1990) |
| "We carried out a prospective, randomized, double-blind, placebo-controlled study to investigate the capacity of aspirin to prevent pregnancy-induced hypertension and to alter prostaglandin metabolism." | 9.06 | The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. ( Barkai, G; Ben-Baruch, G; Blankstein, J; Goldenberg, M; Peleg, E; Rosenthal, T; Ruppin, E; Schiff, E; Tamarkin, M; Yahal, I, 1989) |
| "There is evidence that aspirin in low doses favorably influences the course of pregnancy-induced hypertension, but the mechanism, although assumed to involve suppression of the production of thromboxane by platelets, has not been established." | 9.06 | Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. ( Ballerini, S; Benigni, A; Chiabrando, C; Fanelli, R; Frusca, T; Gregorini, G; Orisio, S; Piccinelli, A; Pinciroli, V; Valcamonico, A, 1989) |
| "The possibility of preventing pregnancy-induced hypertension (PIH) and pre-eclampsia in primigravidae by suppressing production of thromboxane A2 with low-dose aspirin was investigated in a randomised, placebo-controlled, double-blind trial." | 9.06 | Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. ( Dekker, GA; Makovitz, JW; Rotmans, P; Wallenburg, HC, 1986) |
| "This study aimed to investigate whether aspirin use during pregnancy is associated with an increased risk of bleeding complications." | 8.02 | Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study. ( Bergman, L; Hastie, R; Hesselman, S; Sandström, A; Tong, S; Wikström, AK, 2021) |
| "The beneficial effect of aspirin in the prevention of preterm preeclampsia may not apply in pregnancies with chronic hypertension." | 7.85 | Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. ( Akolekar, R; De Stefani, L; Delgado, JL; Evangelinakis, N; Gonzalez-Vanegas, O; Jani, JC; Leipold, G; Nicolaides, KH; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Shearing, S; Syngelaki, A; Tsokaki, T; Wright, D, 2017) |
| " She had discontinued Phenprocoumon-treatment in the 5+4 week of pregnancy by herself." | 7.83 | [Mechanic valve prosthesis and pregnancy: Is Phenprocoumon replaceable?]. ( Gawaz, M; Klee, K; Meyer-Zürn, CS, 2016) |
| " The patient had decided to take low-molecular-weight heparin (LMWH) and aspirin throughout her pregnancy." | 7.74 | Acute thrombosis of a prosthetic mitral valve in pregnancy in spite of adjusted-dose low-molecular-weight heparin and aspirin. ( Curtis, SL; Stuart, AG; Trinder, J, 2008) |
| "Despite an improvement in outcomes in the aspirin treated pregnancy, histologic evidence of uterine vascular pathology persisted in the majority of women with a prior complicated pregnancy demonstrating similar placental lesions." | 7.69 | Low-dose aspirin therapy and placental pathology in women with poor prior pregnancy outcomes. ( Campbell, WA; Cusick, W; Ernst, L; Rodis, JF; Salafia, CM; Vintzileos, AM, 1995) |
| "Low dose Aspirin in pregnancy reduces the incidence of intra uterine growth retardation (IUGR) and pregnancy induced hypertension (PIH) in women at risk for these complications." | 7.68 | Low dose aspirin in pregnancy: a clinical and biochemical study of effects on the newborn. ( Foschini, M; Frusca, T; Soregaroli, M; Tarantini, M; Valcamonico, A, 1993) |
| "Urinary excretion of thromboxane B2 metabolites as markers of thromboxane A2 synthesis was measured in eight patients with moderate to severe pregnancy-induced hypertension and in six normotensive pregnant women at term." | 7.68 | Thromboxane A2 synthesis in pregnancy-induced hypertension. ( Fitzgerald, DJ; FitzGerald, GA; Mayo, G; Murray, R; Rocki, W, 1990) |
| "Pregnant women destined to develop pregnancy-induced hypertension (PIH) lose refractoriness to the pressor effects of infused angiotensin II (A-II) several weeks before the onset of hypertension." | 7.66 | Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy. ( Everett, RB; Gant, NF; MacDonald, PC; Worley, RJ, 1978) |
| "Among women receiving placebo, preeclampsia occurred significantly more often in women with stage 1 hypertension compared with normotensive high-risk women after adjustment for maternal age and body mass index (39." | 6.87 | Aspirin Effect on Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a High-Risk Cohort. ( Caritis, SN; Catov, JM; Hauspurg, A; Sutton, EF, 2018) |
| "Whether low-dose aspirin prevents preeclampsia is unclear." | 6.69 | Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, S; Hauth, J; Klebanoff, M; Landon, M; Lindheimer, MD; Meis, P; Miodovnik, M; Paul, R; Sibai, B; Thom, E; Thurnau, G; VanDorsten, P, 1998) |
| "The incidence of preeclampsia was lower in the aspirin group (69 of 1485 women [4." | 6.67 | Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, SN; Klebanoff, M; McNellis, D; Paul, RH; Rocco, L; Romero, R; Rosen, M; Sibai, BM; Thom, E; Witter, F, 1993) |
| "Chronic hypertension affects 1-5% of women of childbearing age." | 6.66 | Aspirin for the prevention of placenta-mediated complications in pregnant women with chronic hypertension. ( Haddad, B; Lecarpentier, E, 2020) |
| "· High-risk patients who lack a history preeclampsia were less likely to be advised of aspirin use." | 5.62 | Improving Utilization of Aspirin for Prevention of Preeclampsia in a High-Risk Urban Cohort: A Prospective Cohort Study. ( Berghella, V; Boelig, RC; Roman, A; Wanees, M; Zhan, T, 2021) |
| "This study involved the follow-up by questionnaires and hospital records of patients with an ongoing pregnancy in a prospective, randomized, double-blind, placebo-controlled trial on the effect of low-dose aspirin during IVF." | 5.14 | Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. ( Groeneveld, E; Homburg, R; Hompes, PG; Hoozemans, DA; Lambalk, CB; Lambers, MJ; Schats, R, 2009) |
| "In the present study, the incidence of hypertensive pregnancy complications did not differ statistically significantly between low-dose aspirin and placebo groups in unselected IVF/ICSI patients, when medication was started concomitantly with gonadotrophin stimulation and continued until delivery." | 5.14 | Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study. ( Haapsamo, M; Heinonen, S; Martikainen, H; Nuojua-Huttunen, S; Räsänen, J; Tinkanen, H, 2010) |
| "The objectives of the study were to confirm the validity of using oscillometric measurement of MAP in the left lateral position to identify those at high risk for developing pregnancy-induced hypertension (PIH), and to assess and compare the efficacy of prophylaxis with low-dose aspirin or calcium supplementation in high-risk patients." | 5.09 | Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension. ( Fung, HY; Hung, CY; Rogers, MS, 1999) |
| "This study extends previous results on the effects of low-dose aspirin on blood pressure in pregnant women at differing risk of developing hypertension in pregnancy and who received aspirin at different times according to their rest-activity cycle." | 5.09 | Administration time-dependent effects of aspirin in women at differing risk for preeclampsia. ( Alonso, I; Ayala, DE; Codesido, J; Fernández, JR; Hermida, RC; Iglesías, M; Mojón, A; Silva, I; Ucieda, R, 1999) |
| "Of 186 women with abnormal uteroplacental resistance according to criteria defined previously, 102 agreed to randomization to either low-dose aspirin (100 mg/day) or placebo for the remainder of the pregnancy." | 5.08 | A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow. ( Cook, CM; Devonald, KJ; Ellwood, DA; Fay, RA; Morris, JM, 1996) |
| "To analyze determinants of the risk of pregnancy-induced hypertension (PIH) with or without proteinuria, we compared characteristics of women enrolled in the Italian Study of Aspirin in Pregnancy who developed PIH and those who did not." | 5.08 | Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Italian Study of Aspirin in Pregnancy Group. ( Benedetto, C; Bortolus, R; Chatenoud, L; Marozio, L; Parazzini, F; Restelli, S; Ricci, E, 1996) |
| "The aims of this prospective study were to explore the changes in platelet angiotensin II (A-II) binding in pregnancy amongst Chinese women at high risk of developing pregnancy-induced hypertension (PIH) and the effects of low-dose aspirin and calcium supplementation on A-II binding." | 5.08 | Platelet angiotensin II receptor status during pregnancy in Chinese women at high-risk of developing pregnancy-induced hypertension. ( Arumanayagam, M; Hung, C; Rogers, MS, 1996) |
| "We found an association between the addition of ketanserin to aspirin and a decrease in the number of cases of pre-eclampsia and severe hypertension, as well as improved pregnancy outcome among patients with mild to moderate midtrimester hypertension." | 5.08 | Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. ( Odendaal, HJ; Steyn, DW, 1997) |
| "Forty-six nulliparous women in third trimester of pregnancy with a raised blood pressure of 30 mm Hg (systolic) or/and 15 mm Hg (diastolic) or both, over baseline values were treated with 75 mg of aspirin per day." | 5.07 | A study of use of low dose aspirin in prevention of pregnancy induced hypertension. ( Pan, S; Roy, UK, 1994) |
| "Effectiveness of early administered low-dose aspirin in prevention of pregnancy-induced hypertension (PIH) and fetal growth retardation in twin pregnancies was investigated in a randomized placebo controlled, double-blind trial in 47 twin pregnancies." | 5.07 | Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: a preliminary report. ( Arieli, S; Bukovski, I; Caspi, E; Raziel, A; Sherman, D; Weinraub, Z, 1994) |
| "Concern has been expressed about possible neonatal side effects after the use of maternal anti-platelet agents in pregnancy, particularly low dose aspirin treatment." | 5.07 | Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin. ( Broughton Pipkin, F; Fox, SC; Heptinstall, S; Louden, KA; Mitchell, JR; O'Callaghan, C; Symonds, EM; Tuohy, P, 1994) |
| "To study the effect of daily treatment with 50 mg of aspirin (ASA) on the hypertensive pregnancy complications and on the production prostacyclin (PGI2) and thromboxane A2 (TxA2) in high risk pregnant women and their infants." | 5.07 | Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. ( Hartikainen-Sorri, AL; Hiilesmaa, V; Lumme, R; Viinikka, L; Ylikorkala, O, 1993) |
| "Our aim was to test the hypothesis that acetylsalicylate (aspirin) treatment reduces the incidence or severity of pregnancy-associated hypertension." | 5.07 | Low-dose aspirin therapy to prevent preeclampsia. ( Copper, RL; Cutter, GR; DuBard, MB; Goldenberg, RL; Hauth, JC; Parker, CR; Philips, JB, 1993) |
| "In a prospective, randomized, double-blind study for the prevention of pregnancy-induced hypertension and preeclampsia, 41 primigravidae with positive roll-over test (28th-32nd week of pregnancy) received 80 mg aspirin/day or placebo until the end of the 37th week." | 5.07 | Low-dose aspirin in primigravidae with positive roll-over test. ( Alge, A; Dapunt, O; Daxenbichler, G; Hansen, H; Pastner, E; Schröcksnadel, H; Schwegel, P; Sitte, B; Steckel-Berger, G, 1992) |
| "Low dose aspirin would appear to be an appropriate agent for the inhibition of platelet reactivity associated with hypertensive pregnancy." | 5.07 | A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension. ( Broughton Pipkin, F; Fox, S; Heptinstall, S; Louden, KA; Mitchell, JR; O'Callaghan, C; Symonds, EM; Tuohy, P, 1992) |
| "The effect of low doses of aspirin on women with mild pregnancy-induced hypertension was investigated by means of a prospective, randomized, double-blind trial." | 5.06 | Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension. ( Barkai, G; Ben-Baruch, G; Mashiach, S; Schiff, E, 1990) |
| "We carried out a prospective, randomized, double-blind, placebo-controlled study to investigate the capacity of aspirin to prevent pregnancy-induced hypertension and to alter prostaglandin metabolism." | 5.06 | The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. ( Barkai, G; Ben-Baruch, G; Blankstein, J; Goldenberg, M; Peleg, E; Rosenthal, T; Ruppin, E; Schiff, E; Tamarkin, M; Yahal, I, 1989) |
| "There is evidence that aspirin in low doses favorably influences the course of pregnancy-induced hypertension, but the mechanism, although assumed to involve suppression of the production of thromboxane by platelets, has not been established." | 5.06 | Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. ( Ballerini, S; Benigni, A; Chiabrando, C; Fanelli, R; Frusca, T; Gregorini, G; Orisio, S; Piccinelli, A; Pinciroli, V; Valcamonico, A, 1989) |
| "The possibility of preventing pregnancy-induced hypertension (PIH) and pre-eclampsia in primigravidae by suppressing production of thromboxane A2 with low-dose aspirin was investigated in a randomised, placebo-controlled, double-blind trial." | 5.06 | Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. ( Dekker, GA; Makovitz, JW; Rotmans, P; Wallenburg, HC, 1986) |
| " Low-dose aspirin and calcium were identified as candidates for a polypill, with risk reduction estimations for pregnancy-induced hypertension and preeclampsia ranging between 10 and 62 %, depending on patient population characteristics including a priori risk, and gestation age at start of intervention." | 4.93 | Prevention of Hypertensive Disorders of Pregnancy: a Novel Application of the Polypill Concept. ( Browne, JL; Franx, A; Grobbee, DE; Klipstein-Grobusch, K, 2016) |
| "Risk prediction models may be valuable to identify women at risk of pre-eclampsia to guide aspirin prophylaxis in early pregnancy." | 4.93 | The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review. ( Al-Rubaie, Z; Askie, LM; Hudson, HM; Lord, SJ; Ray, JG, 2016) |
| " Despite the widespread use of warfarin and unfractionated heparin during pregnancy, the optimal use of anticoagulants during pregnancy remains controversial because of a lack of appropriate prospective randomized clinical trials." | 4.81 | Anticoagulation during pregnancy. ( Foster, E; Naqvi, TZ, 2002) |
| "This study aimed to investigate whether aspirin use during pregnancy is associated with an increased risk of bleeding complications." | 4.02 | Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study. ( Bergman, L; Hastie, R; Hesselman, S; Sandström, A; Tong, S; Wikström, AK, 2021) |
| "The use of low-dose aspirin in pregnancy should remain a highly targeted indication since its long-term safety has not been established and should be restricted to women at high risk of vascular complications." | 3.85 | [For a targeted use of aspirin]. ( Brun, S; Coatleven, F; Gleyze, M; Lecoq, C; Madar, H; Merlot, B; Nithart, A; Sentilhes, L, 2017) |
| "The beneficial effect of aspirin in the prevention of preterm preeclampsia may not apply in pregnancies with chronic hypertension." | 3.85 | Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. ( Akolekar, R; De Stefani, L; Delgado, JL; Evangelinakis, N; Gonzalez-Vanegas, O; Jani, JC; Leipold, G; Nicolaides, KH; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Shearing, S; Syngelaki, A; Tsokaki, T; Wright, D, 2017) |
| " She had discontinued Phenprocoumon-treatment in the 5+4 week of pregnancy by herself." | 3.83 | [Mechanic valve prosthesis and pregnancy: Is Phenprocoumon replaceable?]. ( Gawaz, M; Klee, K; Meyer-Zürn, CS, 2016) |
| " Prevention with aspirin or heparin was administered in ten cases during pregnancy, and in all the cases with heparin in postpartum." | 3.81 | [Thrombosis risk during pregnancy after history of cerebral venous thrombosis]. ( Neau, JP; Pierre, F; Pouget-Abadie, JF; Pourrat, O, 2015) |
| " This study aims to investigate whether calcium channel blockers plus low dosage aspirin therapy can reduce the incidence of complications during pregnancy with chronic hypertension and improve the prognosis of neonates." | 3.81 | The effect of calcium channel blockers on prevention of preeclampsia in pregnant women with chronic hypertension. ( Jiang, N; Liu, L; Liu, Q; Yang, WW; Zeng, Y, 2015) |
| " Options include continuing oral anticoagulants (OAC) such as warfarin throughout pregnancy, switching from warfarin to unfractionated heparin or low molecular weight heparin (LMWH) in the first trimester then back to warfarin until close to delivery or taking unfractionated heparin or LMWH throughout pregnancy." | 3.77 | Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option. ( McLintock, C, 2011) |
| " A scoring system for VTE risk in pregnant women was developed, each score being associated with a specific treatment: graduated elastic compression stockings, aspirin, prophylactic Low Molecular Weight Heparin (LMWH: variable durations), or adjusted-dose of LMWH through pregnancy and postpartum." | 3.76 | Use of the Delphi method to facilitate antithrombotics prescription during pregnancy. ( Chauleur, C; Decousus, H; Gris, JC; Laporte, S; Mismetti, P; Rancon, F; Varlet, MN, 2010) |
| " The patient had decided to take low-molecular-weight heparin (LMWH) and aspirin throughout her pregnancy." | 3.74 | Acute thrombosis of a prosthetic mitral valve in pregnancy in spite of adjusted-dose low-molecular-weight heparin and aspirin. ( Curtis, SL; Stuart, AG; Trinder, J, 2008) |
| " Fifty-three per cent would advise the use of prophylactic aspirin (75 mg), 49% the use of compression stockings; 4% recommended heparinisation; 44% believed this advice to be applicable only for the 2nd and 3rd trimester, while the RCOG emphasises that the risk of developing venous thromboembolism begins in the 1st trimester." | 3.72 | Thromboembolic disease and air travel in pregnancy: a survey of advice given by obstetricians. ( Cole, R; Iskaros, J; Moriarty, T; Pathak, M; Rodeck, C; Voss, M, 2004) |
| " If thrombophilia was diagnosed on the basis of hyperhomocysteinemia, the treatment consisted of aspirin, pyridoxine and folic acid, instead." | 3.71 | Non-pregnant circulatory volume status predicts subsequent pregnancy outcome in normotensive thrombophilic formerly preeclamptic women. ( Aardenburg, R; de Leeuw, PW; Ekhart, TH; Peeters, LL; Spaanderman, ME; van der Heijden, OW; van Eyck, J; van Eyndhoven, HW, 2001) |
| "This prospective audit reports pregnancy outcomes, anticoagulation complications, and anti-Xa levels in women with mechanical heart valves who were treated with therapeutic enoxaparin plus aspirin during pregnancy." | 3.71 | Enoxaparin treatment in women with mechanical heart valves during pregnancy. ( McCowan, LM; North, RA; Raudkivi, PJ; Rowan, JA, 2001) |
| "In general, aspirin is indicated to prevent thrombosis in conditions associated with high shear rates (i." | 3.70 | Warfarin or aspirin: both or others? ( Peverill, RE, 1999) |
| "Despite an improvement in outcomes in the aspirin treated pregnancy, histologic evidence of uterine vascular pathology persisted in the majority of women with a prior complicated pregnancy demonstrating similar placental lesions." | 3.69 | Low-dose aspirin therapy and placental pathology in women with poor prior pregnancy outcomes. ( Campbell, WA; Cusick, W; Ernst, L; Rodis, JF; Salafia, CM; Vintzileos, AM, 1995) |
| "Low dose Aspirin in pregnancy reduces the incidence of intra uterine growth retardation (IUGR) and pregnancy induced hypertension (PIH) in women at risk for these complications." | 3.68 | Low dose aspirin in pregnancy: a clinical and biochemical study of effects on the newborn. ( Foschini, M; Frusca, T; Soregaroli, M; Tarantini, M; Valcamonico, A, 1993) |
| "Urinary excretion of thromboxane B2 metabolites as markers of thromboxane A2 synthesis was measured in eight patients with moderate to severe pregnancy-induced hypertension and in six normotensive pregnant women at term." | 3.68 | Thromboxane A2 synthesis in pregnancy-induced hypertension. ( Fitzgerald, DJ; FitzGerald, GA; Mayo, G; Murray, R; Rocki, W, 1990) |
| " In five cases, temporary reversal of the HELLP syndrome was achieved using low-dose aspirin and corticosteroids." | 3.68 | Prolongation of premature gestation in women with hemolysis, elevated liver enzymes and low platelets. A report of five cases. ( Burke, MS; Heyborne, KD; Porreco, RP, 1990) |
| "Decreased incidence of proteinuric hypertension after low-dose aspirin therapy is hypothesized to be a consequence of selective thromboxane A2 inhibition and sparing of prostacyclin." | 3.67 | Low-dose aspirin. I. Effect on angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II. ( Brown, CE; Cox, SM; Gant, NF; Magness, RR; Rosenfeld, CR; Spitz, B, 1988) |
| " All women were treated with aspirin (1 g daily or 500 mg every 48 hours) during pregnancy, delivery, and the postdelivery period." | 3.66 | Pregnancy in 20 patients with bioprosthetic valve replacement. ( Gil Aguado, M; Larrea, JL; Matorras, R; Minguez, JA; Nuñez, L; Reque, JA, 1983) |
| "Pregnant women destined to develop pregnancy-induced hypertension (PIH) lose refractoriness to the pressor effects of infused angiotensin II (A-II) several weeks before the onset of hypertension." | 3.66 | Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy. ( Everett, RB; Gant, NF; MacDonald, PC; Worley, RJ, 1978) |
| "Among women receiving placebo, preeclampsia occurred significantly more often in women with stage 1 hypertension compared with normotensive high-risk women after adjustment for maternal age and body mass index (39." | 2.87 | Aspirin Effect on Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a High-Risk Cohort. ( Caritis, SN; Catov, JM; Hauspurg, A; Sutton, EF, 2018) |
| "Women with chronic hypertension are an easily recognized group who are in touch with a wide variety of healthcare providers before, during, and after pregnancy, mandating that chronic hypertension in pregnancy be within the scope of many practitioners." | 2.82 | Toward personalized management of chronic hypertension in pregnancy. ( Kametas, N; Khalil, A; Magee, LA; von Dadelszen, P, 2022) |
| "Hemorrhagic stroke is the most common type of obstetric stroke." | 2.72 | Stroke in Pregnancy: A Multidisciplinary Approach. ( Camargo, EC; Singhal, AB, 2021) |
| "The reduction in the incidence of intrauterine growth retardation (2." | 2.70 | Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. ( Iso-Mustajärvi, M; Kujansuu, E; Mäenpää, J; Vainio, M, 2002) |
| "Whether low-dose aspirin prevents preeclampsia is unclear." | 2.69 | Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, S; Hauth, J; Klebanoff, M; Landon, M; Lindheimer, MD; Meis, P; Miodovnik, M; Paul, R; Sibai, B; Thom, E; Thurnau, G; VanDorsten, P, 1998) |
| "The incidence of preeclampsia was lower in the aspirin group (69 of 1485 women [4." | 2.67 | Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, SN; Klebanoff, M; McNellis, D; Paul, RH; Rocco, L; Romero, R; Rosen, M; Sibai, BM; Thom, E; Witter, F, 1993) |
| "Chronic hypertension affects 1-5% of women of childbearing age." | 2.66 | Aspirin for the prevention of placenta-mediated complications in pregnant women with chronic hypertension. ( Haddad, B; Lecarpentier, E, 2020) |
| "Normal pregnancy is a complex and dynamic process that requires significant adaptation from the maternal system." | 2.66 | Hemodynamic Complications in Pregnancy: Preeclampsia and Beyond. ( Doherty, A; Kingdom, JC; McLaughlin, K, 2020) |
| "Although migraine improves or disappears during pregnancy, a significant association between migraine and hypertension (i." | 2.66 | The Potential Protective Role of Aspirin Against Migraine in Pregnant Women. ( Gong, Y; Liu, X, 2020) |
| "Women with chronic hypertension have a higher incidence of superimposed preeclampsia, cesarean section, preterm delivery before 37 weeks' gestation, birth weight less than 2500 g, neonatal unit admission, and perinatal death." | 2.66 | Hypertension During Pregnancy. ( Agrawal, A; Wenger, NK, 2020) |
| "Pregnancy-induced hypertension is a major cause of maternal and fetal morbidity and mortality." | 2.61 | Hypertension and Pregnancy: Management and Future Risks. ( Jim, B; Reddy, S, 2019) |
| "Pregnancy has a potentially deleterious affect on moyamoya disease (MMD), a cerebrovascular condition characterized by spontaneous occlusion of the distal internal carotid arteries resulting in the neoangiogenesis of fragile collateral blood vessels." | 2.47 | Moyamoya disease in pregnancy: a case series and review of management options. ( Burlingame, JM; Ma, JC, 2011) |
| "Recently, the thrombophilias have been revealed as risk factors for severe preeclampsia, abruptio placentae, fetal growth retardation, abortion and still birth as well." | 2.42 | [Anticoagulation and antiaggregation during pregnancy]. ( Biasiutti, FD; Strebel, JK, 2003) |
| "Aspirin, which was regarded as the drug of choice for the prevention of such obstetric complications, has proved to be ineffective in a large clinical trial." | 2.42 | Inherited thrombophilia and gestational vascular complications. ( Eldor, A; Kupferminc, MJ, 2003) |
| "Many authors relate this factor with preeclampsia, intrauterine fetal growth retardation, spontaneous abortion, unexplained cases of still birth, placental abruption, and thromboembolic complications during and after parturition." | 2.42 | [Factor V Leiden mutation and pregnancy complications]. ( Abraitis, V; Mockeviciene, A; Mongirdiene, A, 2003) |
| "Myocardial infarction is rare in pregnancy." | 2.39 | Myocardial infarction in a parturient. A case report with emphasis on medication and management. ( Haring, P; Hietakorpi, S; Koski, E; Nuutinen, LS; Purhonen, S; Söderlin, MK, 1994) |
| " The dosage of ASA in the majority of works has been about 1,000 mg daily while isolated investigations have shown good effect from doses as low as 60 mg daily." | 2.38 | [Acetylsalicylic acid in the treatment of arterial thromboembolytic diseases. 2. Clinical documentation]. ( Faergeman, O; Fasting, H; Husted, SE; Krusell, LR; Nielsen, HK, 1989) |
| "Normal human pregnancy is characterized by vascular refractoriness to AII." | 2.36 | Control of vascular responsiveness during human pregnancy. ( Everett, RB; Gant, NF; MacDonald, PC; Worley, RJ, 1980) |
| "· High-risk patients who lack a history preeclampsia were less likely to be advised of aspirin use." | 1.62 | Improving Utilization of Aspirin for Prevention of Preeclampsia in a High-Risk Urban Cohort: A Prospective Cohort Study. ( Berghella, V; Boelig, RC; Roman, A; Wanees, M; Zhan, T, 2021) |
| "2." | 1.51 | Management of idiopathic recurrent pericarditis during pregnancy. ( Adler, Y; Brucato, A; Imazio, M; Lucianetti, M; Maestroni, S; Pluymaekers, N; Rampello, S; Tombetti, E; Valenti, A, 2019) |
| "Previous thrombosis, diagnosis of systemic lupus erythematosus (SLE) and triple antiphospholipid (aPL) antibody positivity have recently been found to be independent factors associated to pregnancy failure during conventional therapy in women with antiphospholipid syndrome (APS)." | 1.40 | Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. ( Alijotas-Reig, J; Andreoli, L; Bertero, MT; Bremme, K; Brucato, A; Canti, V; Caramaschi, P; De Carolis, S; Del Ross, T; Di Poi, E; Galeazzi, M; Gerosa, M; Maina, A; Mekinian, A; Meroni, PL; Mosca, M; Ramoni, V; Ruffatti, A; Salvan, E; Tincani, A; Trespidi, L, 2014) |
| "Superimposed preeclampsia occurred in 49 (23." | 1.39 | Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy. ( Cabrol, D; Goffinet, F; Haddad, B; Lecarpentier, E; Sibai, B; Tsatsaris, V, 2013) |
| "Acute myocardial infarction is rare in pregnancy; however, the emerging trend towards advanced maternal age and the rising prevalence of obesity and diabetes suggest that more cases of myocardial infarction are likely to be encountered in pregnancy." | 1.39 | Acute myocardial infarction in pregnancy following unlicensed use of methylenedioxymethamphetamine ('Ecstasy'). ( Dutton, P; Okunoye, GO, 2013) |
| "Syphilis is a treatable condition, screening in pregnancy is both cost effective and cost beneficial." | 1.35 | Stroke in pregnancy associated with syphilis. ( Baker, PN; Bowring, J; Mahto, M; Mandal, D, 2008) |
| "Reproductive failure is common in beta-thalassemia major patients because of endocrine damage resulting from iron overload." | 1.31 | High-risk pregnancy in beta-thalassemia major women. Report of three cases. ( De Marzi, CA; Magliari, F; Perniola, R; Rosatelli, MC, 2000) |
| "Myocardial infarction is rare during pregnancy." | 1.31 | [Myocardial infarction, pregnancy and anesthesia]. ( Diar, N; Rezig, K; Walcker, JL, 2000) |
| "No patients with preeclampsia or other severe complications of pregnancy were observed in the normalised group." | 1.31 | Late normalisation of uterine artery velocimetry in high risk pregnancy. ( Danti, L; Frusca, T; Scalvi, L; Soregaroli, M; Valcamonico, A, 2001) |
| "Pulmonary edema was rare and acute renal failure did not develop in any women." | 1.30 | Safety of labor epidural anesthesia for women with severe hypertensive disease. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. ( Caritis, SN; Dombrowski, MP; Hauth, JC; Hogg, B; Klebanoff, M; Landon, M; Lindheimer, M; MacPherson, C; McNellis, D; Meis, PJ; Miodovnik, M; Paul, R; Roberts, JM; Sibai, BM; Thurnau, GR; Van Dorsten, JP, 1999) |
| "To study treatment of hypertension in pregnancy in Sweden and compare our results with a similar study published in 1981." | 1.29 | How Swedish obstetricians manage hypertensive disorders in pregnancy. A questionnaire study. ( Ingemarsson, I; Montal, S; Wide-Swensson, D, 1994) |
| "Fibromuscular dysplasia is an arteriopathy of unknown etiology that affects the intermediate-size branches of the aorta." | 1.28 | Fibromuscular dysplasia of the carotid arteries complicating pregnancy. ( Beyth, Y; Ezra, Y; Kidron, D, 1989) |
| "A clinical diagnosis of systemic lupus erythematosus (SLE) was made in four women." | 1.27 | Lupus anticoagulant in pregnancy. ( Butler, WS; Liggins, GC; Lubbe, WF; Palmer, SJ, 1984) |
| "Mitral valve prolapse is usually a benign condition, however, serious complications have been reported to be associated with it." | 1.27 | Mitral valve prolapse and thromboembolic disease in pregnancy: a case report. ( Bergh, PA; Breen, JL; Gregori, CA; Hollander, D, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (11.63) | 18.7374 |
| 1990's | 61 (35.47) | 18.2507 |
| 2000's | 48 (27.91) | 29.6817 |
| 2010's | 33 (19.19) | 24.3611 |
| 2020's | 10 (5.81) | 2.80 |
| Authors | Studies |
|---|---|
| Ramlakhan, KP | 1 |
| Johnson, MR | 1 |
| Roos-Hesselink, JW | 1 |
| Lecarpentier, E | 2 |
| Haddad, B | 4 |
| Hastie, R | 1 |
| Tong, S | 1 |
| Wikström, AK | 1 |
| Sandström, A | 1 |
| Hesselman, S | 1 |
| Bergman, L | 1 |
| Magee, LA | 2 |
| Khalil, A | 1 |
| Kametas, N | 1 |
| von Dadelszen, P | 2 |
| Doherty, A | 1 |
| McLaughlin, K | 1 |
| Kingdom, JC | 1 |
| Liu, X | 1 |
| Gong, Y | 1 |
| Agrawal, A | 1 |
| Wenger, NK | 1 |
| Boelig, RC | 1 |
| Wanees, M | 1 |
| Zhan, T | 1 |
| Berghella, V | 1 |
| Roman, A | 1 |
| Booker, WA | 1 |
| Camargo, EC | 1 |
| Singhal, AB | 1 |
| Madar, H | 1 |
| Brun, S | 1 |
| Coatleven, F | 1 |
| Nithart, A | 1 |
| Lecoq, C | 1 |
| Gleyze, M | 1 |
| Merlot, B | 1 |
| Sentilhes, L | 1 |
| Jackson, JR | 1 |
| Gregg, AR | 1 |
| Poon, LC | 1 |
| Wright, D | 1 |
| Rolnik, DL | 1 |
| Syngelaki, A | 1 |
| Delgado, JL | 1 |
| Tsokaki, T | 1 |
| Leipold, G | 1 |
| Akolekar, R | 1 |
| Shearing, S | 1 |
| De Stefani, L | 1 |
| Jani, JC | 1 |
| Plasencia, W | 1 |
| Evangelinakis, N | 1 |
| Gonzalez-Vanegas, O | 1 |
| Persico, N | 1 |
| Nicolaides, KH | 1 |
| Prefumo, F | 1 |
| Frusca, T | 4 |
| Valensise, H | 2 |
| Hauspurg, A | 1 |
| Sutton, EF | 1 |
| Catov, JM | 1 |
| Caritis, SN | 3 |
| Chahine, KM | 1 |
| Sibai, BM | 5 |
| Brucato, A | 4 |
| Pluymaekers, N | 1 |
| Tombetti, E | 1 |
| Rampello, S | 2 |
| Maestroni, S | 1 |
| Lucianetti, M | 1 |
| Valenti, A | 1 |
| Adler, Y | 2 |
| Imazio, M | 3 |
| Reddy, S | 1 |
| Jim, B | 1 |
| Chung, EYM | 1 |
| Tiku, A | 1 |
| Seeho, S | 1 |
| Mather, A | 1 |
| Tsatsaris, V | 1 |
| Goffinet, F | 2 |
| Cabrol, D | 1 |
| Sibai, B | 2 |
| Okunoye, GO | 1 |
| Dutton, P | 1 |
| Pourrat, O | 1 |
| Neau, JP | 1 |
| Pouget-Abadie, JF | 1 |
| Pierre, F | 1 |
| Bushnell, C | 1 |
| McCullough, L | 1 |
| Ruffatti, A | 1 |
| Salvan, E | 1 |
| Del Ross, T | 1 |
| Gerosa, M | 1 |
| Andreoli, L | 1 |
| Maina, A | 1 |
| Alijotas-Reig, J | 1 |
| De Carolis, S | 3 |
| Mekinian, A | 1 |
| Bertero, MT | 1 |
| Canti, V | 1 |
| Bremme, K | 1 |
| Ramoni, V | 1 |
| Mosca, M | 1 |
| Di Poi, E | 1 |
| Caramaschi, P | 1 |
| Galeazzi, M | 1 |
| Tincani, A | 1 |
| Trespidi, L | 1 |
| Meroni, PL | 1 |
| Jiang, N | 1 |
| Liu, Q | 1 |
| Liu, L | 1 |
| Yang, WW | 1 |
| Zeng, Y | 1 |
| Ismail, AM | 1 |
| Hamed, AH | 1 |
| Saso, S | 1 |
| Abu-Elhasan, AM | 1 |
| Abu-Elghar, MM | 1 |
| Abdelmeged, AN | 1 |
| Klee, K | 1 |
| Gawaz, M | 1 |
| Meyer-Zürn, CS | 1 |
| Browne, JL | 1 |
| Klipstein-Grobusch, K | 1 |
| Franx, A | 1 |
| Grobbee, DE | 1 |
| Al-Rubaie, Z | 1 |
| Askie, LM | 1 |
| Ray, JG | 1 |
| Hudson, HM | 1 |
| Lord, SJ | 1 |
| Shanmugalingam, R | 1 |
| Reza Pour, N | 1 |
| Chuah, SC | 1 |
| Vo, TM | 1 |
| Beran, R | 1 |
| Hennessy, A | 1 |
| Makris, A | 1 |
| Lim, W | 1 |
| Bates, SM | 1 |
| Greer, IA | 2 |
| Pabinger, I | 1 |
| Sofaer, S | 1 |
| Hirsh, J | 2 |
| Bowring, J | 1 |
| Mahto, M | 1 |
| Mandal, D | 1 |
| Baker, PN | 2 |
| Skrzypczak, J | 1 |
| Turtzo, LC | 1 |
| McCullough, LD | 1 |
| Bernardon, M | 1 |
| Limone, A | 1 |
| Businelli, C | 1 |
| Maso, GP | 1 |
| Piccoli, M | 1 |
| Alberico, S | 1 |
| Helms, AK | 1 |
| Drogan, O | 1 |
| Kittner, SJ | 1 |
| Curri, S | 1 |
| Palmieri, G | 1 |
| Trinchero, R | 2 |
| Lambers, MJ | 1 |
| Groeneveld, E | 1 |
| Hoozemans, DA | 1 |
| Schats, R | 1 |
| Homburg, R | 1 |
| Lambalk, CB | 1 |
| Hompes, PG | 1 |
| Sankar, A | 1 |
| Hinshaw, K | 1 |
| Quinn, J | 1 |
| Von Klemperer, K | 1 |
| Brooks, R | 1 |
| Peebles, D | 1 |
| Walker, F | 1 |
| Cohen, H | 1 |
| Chauleur, C | 3 |
| Gris, JC | 3 |
| Laporte, S | 2 |
| Rancon, F | 1 |
| Varlet, MN | 2 |
| Decousus, H | 2 |
| Mismetti, P | 2 |
| Armellino, F | 1 |
| Spodick, DH | 1 |
| Haapsamo, M | 1 |
| Martikainen, H | 1 |
| Tinkanen, H | 1 |
| Heinonen, S | 1 |
| Nuojua-Huttunen, S | 1 |
| Räsänen, J | 1 |
| McLintock, C | 1 |
| Deane, KD | 1 |
| Tyler, KN | 1 |
| Johnson, DW | 1 |
| Tanabe, JL | 1 |
| Oskarrson, BE | 1 |
| Nitka, EE | 1 |
| Brass, E | 1 |
| Davies, JK | 1 |
| Striebich, CC | 1 |
| Ma, JC | 1 |
| Burlingame, JM | 1 |
| Molinari, N | 1 |
| Marès, P | 2 |
| Fabbro-Peray, P | 1 |
| Quéré, I | 2 |
| Lefrant, JY | 1 |
| Dauzat, M | 2 |
| Ames, M | 1 |
| Rueda, J | 1 |
| Caughey, AB | 1 |
| Ayala, DE | 2 |
| Ucieda, R | 2 |
| Hermida, RC | 2 |
| Mravian, SR | 1 |
| Petrukhin, VA | 1 |
| Davydova, TV | 1 |
| Budykina, TS | 1 |
| Tishenina, RS | 1 |
| Pronina, VP | 1 |
| Grishin, VL | 1 |
| Naqvi, TZ | 1 |
| Foster, E | 1 |
| Vilela, VS | 1 |
| de Jesús, NR | 1 |
| Levy, RA | 1 |
| Inbal, A | 1 |
| Czestochowska, E | 1 |
| Qureshi, ZP | 1 |
| Biasiutti, FD | 1 |
| Strebel, JK | 1 |
| Kupferminc, MJ | 1 |
| Eldor, A | 1 |
| Vainio, M | 4 |
| Riutta, A | 3 |
| Koivisto, AM | 2 |
| Mäenpää, J | 4 |
| Abraitis, V | 1 |
| Mongirdiene, A | 1 |
| Mockeviciene, A | 1 |
| Mercier, E | 1 |
| Lavigne-Lissalde, G | 1 |
| Cochery-Nouvellon, E | 1 |
| Hoffet, M | 1 |
| Ripart-Neveu, S | 1 |
| Tailland, ML | 1 |
| Wilson, AM | 1 |
| Boyle, AJ | 1 |
| Fox, P | 1 |
| Ezemba, N | 1 |
| Eze, JC | 1 |
| Onah, HE | 1 |
| Anisiuba, BC | 1 |
| Aghaji, MA | 1 |
| Ezike, HA | 1 |
| Nicolas, X | 1 |
| Le Berre, R | 1 |
| Ansart, S | 1 |
| Pennec, YL | 1 |
| Voss, M | 1 |
| Cole, R | 1 |
| Moriarty, T | 1 |
| Pathak, M | 1 |
| Iskaros, J | 1 |
| Rodeck, C | 1 |
| Faivre, L | 1 |
| Meerpohl, J | 1 |
| Da Costa, L | 1 |
| Marie, I | 1 |
| Nouvel, C | 1 |
| Gnekow, A | 1 |
| Bender-Götze, C | 1 |
| Bauters, F | 1 |
| Coiffier, B | 1 |
| Peaud, PY | 1 |
| Rispal, P | 1 |
| Berrebi, A | 1 |
| Berger, C | 1 |
| Flesch, M | 1 |
| Sagot, P | 1 |
| Varet, B | 1 |
| Niemeyer, C | 1 |
| Tchernia, G | 1 |
| Leblanc, T | 1 |
| Tsuda, E | 1 |
| Kawamata, K | 1 |
| Neki, R | 1 |
| Echigo, S | 1 |
| Chiba, Y | 1 |
| Frishman, WH | 1 |
| Veresh, M | 1 |
| Schlocker, SJ | 1 |
| Tejani, N | 1 |
| Descarries, LM | 1 |
| Leduc, L | 1 |
| Khairy, P | 1 |
| Mercier, LA | 1 |
| Walsh, CA | 1 |
| Manias, T | 1 |
| Patient, C | 1 |
| Srivastava, AR | 1 |
| Modi, P | 1 |
| Sahi, S | 1 |
| Niwariya, Y | 1 |
| Singh, H | 1 |
| Banerjee, A | 1 |
| Vij, M | 1 |
| Mowbray, D | 1 |
| Bessereau, J | 1 |
| Desvignes, O | 1 |
| Huon, B | 1 |
| Roudaut, JY | 1 |
| Picault, L | 1 |
| Blanc, JJ | 1 |
| Quenet, S | 1 |
| Seffert, P | 1 |
| Curtis, SL | 1 |
| Trinder, J | 1 |
| Stuart, AG | 1 |
| Fernández-Meré, LA | 1 |
| Fernández Rogríguez, S | 1 |
| Alvarez-Blanco, M | 1 |
| Al-Aqeedi, RF | 1 |
| Al-Nabti, AD | 1 |
| Gant, NF | 5 |
| Worley, RJ | 3 |
| Everett, RB | 3 |
| MacDonald, PC | 3 |
| Lubbe, WF | 1 |
| Butler, WS | 1 |
| Palmer, SJ | 1 |
| Liggins, GC | 1 |
| Nuñez, L | 1 |
| Larrea, JL | 1 |
| Gil Aguado, M | 1 |
| Reque, JA | 1 |
| Matorras, R | 1 |
| Minguez, JA | 1 |
| Biale, Y | 1 |
| Cantor, A | 1 |
| Lewenthal, H | 1 |
| Gueron, M | 1 |
| Wechsler, B | 1 |
| Généreau, T | 1 |
| Biousse, V | 1 |
| Vauthier-Brouzes, D | 1 |
| Seebacher, J | 1 |
| Dormont, D | 1 |
| Godeau, P | 1 |
| Hamid, R | 1 |
| Robson, M | 1 |
| Pearce, JM | 2 |
| Rienhardt, GW | 1 |
| Steyn, PS | 1 |
| Odendaal, HJ | 2 |
| Beaufils, M | 3 |
| Uzan, S | 3 |
| Bréart, G | 2 |
| Williams, K | 1 |
| Söderlin, MK | 1 |
| Purhonen, S | 1 |
| Haring, P | 1 |
| Hietakorpi, S | 1 |
| Koski, E | 1 |
| Nuutinen, LS | 1 |
| Tunbridge, RD | 1 |
| Roy, UK | 1 |
| Pan, S | 1 |
| Romanini, C | 1 |
| Ginsberg, JS | 2 |
| Barron, WM | 1 |
| Wide-Swensson, D | 1 |
| Montal, S | 1 |
| Ingemarsson, I | 1 |
| Porreco, RP | 2 |
| Hickok, DE | 1 |
| Williams, MA | 1 |
| Krenning, C | 1 |
| Gonser, M | 1 |
| Marzusch, K | 1 |
| Louden, KA | 3 |
| Caspi, E | 1 |
| Raziel, A | 1 |
| Sherman, D | 1 |
| Arieli, S | 1 |
| Bukovski, I | 1 |
| Weinraub, Z | 1 |
| Broughton Pipkin, F | 2 |
| Heptinstall, S | 2 |
| Fox, SC | 1 |
| Tuohy, P | 2 |
| O'Callaghan, C | 2 |
| Mitchell, JR | 2 |
| Symonds, EM | 2 |
| Viinikka, L | 1 |
| Hartikainen-Sorri, AL | 1 |
| Lumme, R | 1 |
| Hiilesmaa, V | 1 |
| Ylikorkala, O | 1 |
| Valcamonico, A | 3 |
| Foschini, M | 1 |
| Soregaroli, M | 2 |
| Tarantini, M | 1 |
| Gull, S | 1 |
| Prentice, A | 1 |
| Meagher, EA | 1 |
| FitzGerald, GA | 2 |
| Thom, E | 2 |
| Klebanoff, M | 3 |
| McNellis, D | 2 |
| Rocco, L | 1 |
| Paul, RH | 1 |
| Romero, R | 1 |
| Witter, F | 1 |
| Rosen, M | 1 |
| Hauth, JC | 2 |
| Goldenberg, RL | 1 |
| Parker, CR | 1 |
| Philips, JB | 1 |
| Copper, RL | 1 |
| DuBard, MB | 1 |
| Cutter, GR | 1 |
| Morris, JM | 2 |
| Fay, RA | 1 |
| Ellwood, DA | 1 |
| Cook, CM | 1 |
| Devonald, KJ | 1 |
| McCoy, MC | 1 |
| Wang, Y | 1 |
| Coffman, TM | 1 |
| Killam, AP | 1 |
| Kay, HH | 1 |
| Cusick, W | 1 |
| Salafia, CM | 1 |
| Ernst, L | 1 |
| Rodis, JF | 1 |
| Campbell, WA | 1 |
| Vintzileos, AM | 1 |
| McCowan, LM | 2 |
| Buist, RG | 1 |
| North, RA | 2 |
| Gamble, G | 1 |
| Parazzini, F | 1 |
| Bortolus, R | 1 |
| Chatenoud, L | 1 |
| Restelli, S | 1 |
| Ricci, E | 1 |
| Marozio, L | 1 |
| Benedetto, C | 1 |
| Rogers, MS | 2 |
| Hung, C | 1 |
| Arumanayagam, M | 1 |
| Steyn, DW | 1 |
| Caritis, S | 1 |
| Hauth, J | 1 |
| Lindheimer, MD | 1 |
| VanDorsten, P | 1 |
| Landon, M | 2 |
| Paul, R | 2 |
| Miodovnik, M | 2 |
| Meis, P | 1 |
| Thurnau, G | 1 |
| Sebastian, C | 1 |
| Scherlag, M | 1 |
| Kugelmass, A | 1 |
| Schechter, E | 1 |
| Ylitalo, P | 1 |
| Ala-Fossi, SL | 1 |
| Tuimala, R | 1 |
| Fung, HY | 1 |
| Hung, CY | 1 |
| Fernández, JR | 1 |
| Mojón, A | 1 |
| Alonso, I | 1 |
| Silva, I | 1 |
| Codesido, J | 1 |
| Iglesías, M | 1 |
| Peverill, RE | 1 |
| Hogg, B | 1 |
| Lindheimer, M | 1 |
| Van Dorsten, JP | 1 |
| MacPherson, C | 1 |
| Meis, PJ | 1 |
| Thurnau, GR | 1 |
| Dombrowski, MP | 1 |
| Roberts, JM | 1 |
| Perniola, R | 1 |
| Magliari, F | 1 |
| Rosatelli, MC | 1 |
| De Marzi, CA | 1 |
| Randi, ML | 1 |
| Rossi, C | 1 |
| Fabris, F | 1 |
| Girolami, A | 1 |
| Rezig, K | 1 |
| Diar, N | 1 |
| Walcker, JL | 1 |
| Bar, J | 1 |
| Mashiah, R | 1 |
| Cohen-Sacher, B | 1 |
| Hod, M | 1 |
| Orvieto, R | 1 |
| Ben-Rafael, Z | 1 |
| Lahav, J | 1 |
| Scalvi, L | 1 |
| Danti, L | 1 |
| Roberts, N | 1 |
| Ross, D | 1 |
| Flint, SK | 1 |
| Arya, R | 1 |
| Blott, M | 1 |
| Spaanderman, ME | 1 |
| Aardenburg, R | 1 |
| Ekhart, TH | 1 |
| van Eyndhoven, HW | 1 |
| van der Heijden, OW | 1 |
| van Eyck, J | 1 |
| de Leeuw, PW | 1 |
| Peeters, LL | 1 |
| Rowan, JA | 1 |
| Raudkivi, PJ | 1 |
| Pauzner, R | 1 |
| Dulitzki, M | 1 |
| Langevitz, P | 2 |
| Livneh, A | 1 |
| Kenett, R | 1 |
| Many, A | 1 |
| Kujansuu, E | 1 |
| Iso-Mustajärvi, M | 1 |
| Myers, JE | 1 |
| Soriano, D | 1 |
| Carp, H | 1 |
| Seidman, DS | 1 |
| Schiff, E | 3 |
| Mashiach, S | 2 |
| Dulitzky, M | 1 |
| Chand, S | 1 |
| Ben Ismail, M | 1 |
| Ghariani, M | 1 |
| Jais, JM | 1 |
| Miller, JJ | 1 |
| Fries, JF | 1 |
| Schröcksnadel, H | 1 |
| Sitte, B | 1 |
| Alge, A | 1 |
| Steckel-Berger, G | 1 |
| Schwegel, P | 1 |
| Pastner, E | 1 |
| Daxenbichler, G | 1 |
| Hansen, H | 1 |
| Dapunt, O | 1 |
| Elliott, JP | 1 |
| Radin, TG | 1 |
| Fox, S | 1 |
| Caruso, A | 2 |
| Ferrazzani, S | 2 |
| Lanzone, A | 1 |
| Mancuso, S | 1 |
| Dildy, GA | 1 |
| Clark, SL | 1 |
| Imperiale, TF | 1 |
| Petrulis, AS | 1 |
| Wallenburg, HC | 2 |
| Cornélissen, G | 2 |
| Halberg, F | 1 |
| Prikryl, P | 1 |
| Danková, E | 1 |
| Siegelová, J | 1 |
| Dusek, J | 1 |
| Fitzgerald, DJ | 1 |
| Rocki, W | 1 |
| Murray, R | 1 |
| Mayo, G | 1 |
| McParland, P | 1 |
| Chamberlain, GV | 1 |
| Barkai, G | 2 |
| Ben-Baruch, G | 2 |
| Hillman, D | 1 |
| Di Giglio, R | 1 |
| Vercillo Martino, I | 1 |
| Pometti, A | 1 |
| Tocci, A | 1 |
| Kato, J | 1 |
| Brown, CE | 2 |
| Cox, K | 1 |
| Spitz, B | 2 |
| Rosenfeld, CR | 2 |
| Magness, RR | 2 |
| Hertz-Picciotto, I | 1 |
| Hopenhayn-Rich, C | 1 |
| Golub, M | 1 |
| Hooper, K | 1 |
| Herschman, Z | 1 |
| Klapholz, A | 1 |
| Heyborne, KD | 1 |
| Burke, MS | 1 |
| Hachicha, J | 1 |
| Ammous, A | 1 |
| Damak, J | 1 |
| Hammami, M | 1 |
| Ghorbel, A | 1 |
| Rekik, S | 1 |
| Jarraya, A | 1 |
| Peleg, E | 1 |
| Goldenberg, M | 1 |
| Rosenthal, T | 1 |
| Ruppin, E | 1 |
| Tamarkin, M | 1 |
| Yahal, I | 1 |
| Blankstein, J | 1 |
| Benigni, A | 1 |
| Gregorini, G | 1 |
| Chiabrando, C | 1 |
| Ballerini, S | 1 |
| Orisio, S | 1 |
| Piccinelli, A | 1 |
| Pinciroli, V | 1 |
| Fanelli, R | 1 |
| Nielsen, HK | 1 |
| Husted, SE | 1 |
| Krusell, LR | 1 |
| Fasting, H | 1 |
| Faergeman, O | 1 |
| Ezra, Y | 1 |
| Kidron, D | 1 |
| Beyth, Y | 1 |
| Dekker, GA | 1 |
| Makovitz, JW | 1 |
| Rotmans, P | 1 |
| Elder, MG | 1 |
| de Swiet, M | 1 |
| Robertson, A | 1 |
| Elder, MA | 1 |
| Flloyd, E | 1 |
| Hawkins, DF | 1 |
| Bergh, PA | 1 |
| Hollander, D | 1 |
| Gregori, CA | 1 |
| Breen, JL | 1 |
| Rubin, PC | 1 |
| Horn, L | 1 |
| Cox, SM | 1 |
| Walker, JJ | 1 |
| Forbes, CD | 1 |
| Calder, AA | 1 |
| Weiner, CP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Clinical Trial of Using Preconceptional Enoxaparin AND Low Dose Aspirin 81mg in Patient With Antiphospholipid Syndrome(APS)[NCT01661439] | 316 participants (Anticipated) | Observational | 2012-03-31 | Recruiting | |||
| Thromboelastography to Assess Age-Related Coagulation Differences in Patients Undergoing Elective Cesarean Delivery.[NCT01416454] | 46 participants (Actual) | Observational | 2010-10-31 | Completed | |||
| Prevention of Preeclampsia With Aspirin Administered From the Beginning of Pregnancy in Recipients of Donated Oocytes.[NCT02174328] | Phase 3 | 81 participants (Actual) | Interventional | 2014-05-21 | Terminated (stopped due to Halted prematurely due to low recruitment rate.) | ||
| Prospective Multicentric Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women With a Risk of Thromboembolism and/or a Risk of Placental Vascular Complication, Strategy Determined With a Risk Score.[NCT00745212] | 2,280 participants (Actual) | Observational | 2008-06-30 | Completed | |||
| The Significance of Low-Dose Aspirin on Ovarian Responsiveness, Uterine Hemodynamics and Pregnancy Outcome in in Vitro Fertilization and in Intracytoplasmic Sperm Injection: A Randomized, Placebo-Controlled Double-Blind Study[NCT00683202] | 374 participants (Actual) | Interventional | 2001-03-31 | Completed | |||
| Early Versus Late Post Caesarean Section Oral Anticoagulation Initiation and Risk of Maternal Complications in Patients With Mechanical Heart Valve Prosthesis[NCT04855110] | 114 participants (Anticipated) | Interventional | 2021-04-19 | Recruiting | |||
| Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers[NCT01729468] | Phase 4 | 1,106 participants (Actual) | Interventional | 2012-06-27 | Completed | ||
| A Randomized Controlled Trial Comparing Low Doses Of Aspirin In The Prevention Of Preeclampsia (ASAPP)[NCT04070573] | Phase 3 | 400 participants (Anticipated) | Interventional | 2019-10-21 | Enrolling by invitation | ||
| Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)[NCT02409680] | 11,976 participants (Actual) | Interventional | 2016-03-23 | Completed | |||
| A Comparison of Fetal Hemodynamic Measurements Between Pregnant Women Taking Anti-hypertensive Medication and Controls[NCT00759278] | 0 participants (Actual) | Observational | 2008-08-31 | Withdrawn (stopped due to No participants) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
- Early preterm delivery (<34 weeks) (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 189 |
| Placebo Arm | 230 |
- Birth weight <2500g (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 1078 |
| Placebo Arm | 1153 |
- Birth weight <1500g (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 78 |
| Placebo Arm | 101 |
- Incidence of Fetal Loss (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 303 |
| Placebo Arm | 353 |
- Incidence of Spontaneous Abortion (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 134 |
| Placebo Arm | 152 |
- Incidence of All stillbirth (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 141 |
| Placebo Arm | 166 |
- Incidence of Medical Termination of Pregnancy (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 42 |
| Placebo Arm | 30 |
- Hypertensive disorders of pregnancy is defined by the characterization of evidence of a hypertensive disorder, including either preeclampsia or eclampsia occurring during the pregnancy. (NCT02409680)
Timeframe: Evidence of hypertensive disorder during the pregnancy (prior to delivery/birth)
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 352 |
| Placebo Arm | 325 |
- Incidence of Perinatal Mortality (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 264 |
| Placebo Arm | 309 |
The primary outcome of this study is incidence of preterm birth, which will be defined as delivery at or after 20 0/7 weeks and prior to 37 0/7 weeks. This will be determined based on actual date of delivery in comparison to the projected estimated due date (EDD), independent of whether or not the preterm delivery is indicated or spontaneous. (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 668 |
| Placebo Arm | 754 |
- Small for gestational age (SGA) as defined by the INTERGROWTH-21st standard (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 1506 |
| Placebo Arm | 1564 |
- Vaginal bleeding (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 214 |
| Placebo Arm | 246 |
- Antepartum hemorrhage (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 26 |
| Placebo Arm | 25 |
- Postpartum hemorrhage (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 54 |
| Placebo Arm | 43 |
- Incidence of Maternal Mortality (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 9 |
| Placebo Arm | 12 |
- Incidence of Late Abortion (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 23 |
| Placebo Arm | 30 |
Hemoglobin < 7.0 gm/dl at 26-30 weeks gestation or a drop of 3.5+ gm/dl from screening to 26-30 weeks gestation (NCT02409680)
Timeframe: At enrollment, 4 weeks post enrollment, and 26-30 weeks GA.
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 290 |
| Placebo Arm | 333 |
Early preterm delivery (<34 weeks) and hypertensive disorders (i.e.: preeclampsia) (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 8 |
| Placebo Arm | 21 |
49 reviews available for aspirin and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Pregnancy and cardiovascular disease.
Topics: Acute Coronary Syndrome; Antihypertensive Agents; Aortic Dissection; Arrhythmias, Cardiac; Aspirin; | 2020 |
Aspirin for the prevention of placenta-mediated complications in pregnant women with chronic hypertension.
Topics: Aspirin; Female; France; Humans; Hypertension; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complic | 2020 |
Toward personalized management of chronic hypertension in pregnancy.
Topics: Antihypertensive Agents; Aspirin; Blood Pressure Monitoring, Ambulatory; Calcium; Chronic Disease; C | 2022 |
Hemodynamic Complications in Pregnancy: Preeclampsia and Beyond.
Topics: Anticonvulsants; Antihypertensive Agents; Aspirin; Delivery, Obstetric; Female; Fetal Growth Retarda | 2020 |
The Potential Protective Role of Aspirin Against Migraine in Pregnant Women.
Topics: Aspirin; Drug Administration Schedule; Drug Dosage Calculations; Endothelium, Vascular; Female; Huma | 2020 |
Hypertension During Pregnancy.
Topics: Aspirin; Cesarean Section; Female; Humans; Hypertension; Infant, Newborn; Pre-Eclampsia; Pregnancy; | 2020 |
Hypertensive Disorders of Pregnancy.
Topics: Anticonvulsants; Antihypertensive Agents; Aspirin; Chronic Disease; Delivery, Obstetric; Eclampsia; | 2020 |
Stroke in Pregnancy: A Multidisciplinary Approach.
Topics: Aspirin; Brain Diseases; Cardiomyopathies; Cesarean Section; Eclampsia; Embolism, Paradoxical; Femal | 2021 |
Updates on the Recognition, Prevention and Management of Hypertension in Pregnancy.
Topics: Aspirin; Female; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregation Inhibitors; Pregnancy | 2017 |
Hypertension and Pregnancy: Management and Future Risks.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Chronic Disease; Diuretics; Female; Human | 2019 |
Prevention of Hypertensive Disorders of Pregnancy: a Novel Application of the Polypill Concept.
Topics: Antihypertensive Agents; Aspirin; Calcium, Dietary; Drug Therapy, Combination; Female; Humans; Hyper | 2016 |
The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.
Topics: Aspirin; Blood Pressure; Decision Support Techniques; Female; Fertilization; Humans; Hypertension; M | 2016 |
Vertebral artery dissection in hypertensive disorders of pregnancy: a case series and literature review.
Topics: Adult; Antihypertensive Agents; Aspirin; Blood Pressure; Computed Tomography Angiography; Female; Hu | 2016 |
Preventing deaths due to the hypertensive disorders of pregnancy.
Topics: Aspirin; Birth Intervals; Calcium; Cardiotocography; Dietary Supplements; Eclampsia; Female; Food Su | 2016 |
Prevention of thrombosis in antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Humans; Male; Pregnancy; Pregnancy | 2016 |
[The management of pregnant women with antiphospholipid syndrome].
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; | 2007 |
Sex differences in stroke.
Topics: Acute Disease; Age Factors; Animals; Aspirin; Atrial Fibrillation; Carotid Stenosis; Cerebrovascular | 2008 |
Management of pericardial diseases during pregnancy.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Aspirin; Colchicine; Contraindications; Cyclooxyg | 2010 |
Moyamoya disease in pregnancy: a case series and review of management options.
Topics: Adult; Aspirin; Cerebral Revascularization; Female; Hawaii; Humans; Infant, Newborn; Moyamoya Diseas | 2011 |
Ambulatory management of chronic hypertension in pregnancy.
Topics: Ambulatory Care; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Disease | 2012 |
Anticoagulation during pregnancy.
Topics: Adult; Anticoagulants; Aspirin; Female; Heart Valve Prosthesis; Heparin; Humans; Practice Guidelines | 2002 |
Prevention of thrombosis during pregnancy.
Topics: Administration, Oral; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Blood Coagulation Tests; B | 2002 |
[Antithrombotic prophylaxis in pregnancy].
Topics: Aspirin; Factor V; Female; Fibrinolytic Agents; Humans; Mutation; Pregnancy; Pregnancy Complications | 2001 |
Current management of hypertensive disease in pregnancy.
Topics: Anticonvulsants; Antihypertensive Agents; Aspirin; Calcium, Dietary; Delivery, Obstetric; Female; Hu | 2002 |
[Anticoagulation and antiaggregation during pregnancy].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abruptio Placentae; Administration, Oral; Adult; | 2003 |
Inherited thrombophilia and gestational vascular complications.
Topics: Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications; Pregnanc | 2003 |
[Factor V Leiden mutation and pregnancy complications].
Topics: Abortion, Spontaneous; Activated Protein C Resistance; Adult; Anticoagulants; Aspirin; Factor V; Fem | 2003 |
Pathophysiology and medical management of systemic hypertension and pre-eclampsia in pregnancy.
Topics: Adult; Antihypertensive Agents; Aspirin; Blood Pressure Determination; Calcium, Dietary; Chronic Dis | 2006 |
Anticoagulation for pregnant patients with mechanical heart valves.
Topics: Abortion, Spontaneous; Anticoagulants; Aspirin; Drug Administration Schedule; Female; Fetal Diseases | 2007 |
Control of vascular responsiveness during human pregnancy.
Topics: 20-alpha-Dihydroprogesterone; Angiotensin II; Aspirin; Blood Vessels; Cyclic AMP; Female; Humans; Hy | 1980 |
[Aspirin and pregnancy: present data and future perspectives].
Topics: Aspirin; Controlled Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hypertension; Placent | 1995 |
Hypertension in pregnancy.
Topics: Antihypertensive Agents; Aspirin; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, | 1995 |
Myocardial infarction in a parturient. A case report with emphasis on medication and management.
Topics: Adult; Aspirin; Atenolol; Delivery, Obstetric; Drug Therapy, Combination; Female; Humans; Myocardial | 1994 |
The management of pregnancy in hypertensive patients.
Topics: Adult; Antihypertensive Agents; Aspirin; Blood Pressure; Congenital Abnormalities; Female; Humans; H | 1994 |
Is low-dose aspirin effective in preventing hypertension in pregnancy?
Topics: Aspirin; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovasc | 1994 |
[Pregnancy nephropathies].
Topics: Adult; Antihypertensive Agents; Aspirin; Epoprostenol; Female; Hemostasis; Humans; Hypertension; Kid | 1993 |
Disordered eicosanoid formation in pregnancy-induced hypertension.
Topics: Aspirin; Eicosanoids; Epoprostenol; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications | 1993 |
Chronic hypertension in pregnancy.
Topics: Abruptio Placentae; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin | 1999 |
Hypertensive diseases and eclampsia.
Topics: Antihypertensive Agents; Antioxidants; Aspirin; Eclampsia; Endothelial Growth Factors; Endothelium, | 2002 |
Vascular reactivity to angiotensin II in human pregnancy.
Topics: Adolescent; Angiotensin II; Animals; Aspirin; Blood Pressure; Blood Volume; Dogs; Female; Haplorhini | 1978 |
Use of antithrombotic agents during pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fetal Diseases; Hemorrhage; Humans; Oste | 1992 |
Recent developments in pregnancy-induced hypertension.
Topics: Anticonvulsants; Antihypertensive Agents; Aspirin; Diagnosis, Differential; Female; Humans; Hyperten | 1991 |
A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease.
Topics: Aspirin; Cesarean Section; Clinical Trials as Topic; Female; Humans; Hypertension; Infant, Low Birth | 1991 |
Low-dose aspirin to prevent pregnancy-induced hypertensive disease.
Topics: Aspirin; Female; Humans; Hypertension; Meta-Analysis as Topic; Pregnancy; Pregnancy Complications, C | 1991 |
Diagnosis and management of chronic hypertension in pregnancy.
Topics: Abruptio Placentae; Antihypertensive Agents; Aspirin; Blood Pressure Determination; Female; Humans; | 1991 |
[Acetylsalicylic acid and pregnancy hypertension].
Topics: Aspirin; Epoprostenol; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complicatio | 1991 |
The risks and benefits of taking aspirin during pregnancy.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Female; Fetus; Hemorrhage; Humans; Infant, Newborn; P | 1990 |
[Acetylsalicylic acid in the treatment of arterial thromboembolytic diseases. 2. Clinical documentation].
Topics: Aspirin; Cardiac Surgical Procedures; Diabetic Angiopathies; Female; Glomerulonephritis, Membranopro | 1989 |
Diagnosis and management of thromboembolic disease during pregnancy.
Topics: Acute Disease; Aspirin; Bacterial Infections; Female; Heparin; Humans; Ovary; Phlebography; Plethysm | 1985 |
38 trials available for aspirin and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Aspirin Effect on Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a High-Risk Cohort.
Topics: Adult; Aspirin; Blood Pressure; Body Mass Index; Cyclooxygenase Inhibitors; Dose-Response Relationsh | 2018 |
Randomized controlled study of pre-conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Egypt; Eno | 2016 |
Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy.
Topics: Adult; Aspirin; Double-Blind Method; Female; Fertilization in Vitro; Humans; Hypertension, Pregnancy | 2009 |
Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience.
Topics: Anticoagulants; Aspirin; Factor Xa Inhibitors; Female; Heart Valve Prosthesis; Hemorrhage; Heparin, | 2009 |
Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study.
Topics: Adult; Aspirin; Double-Blind Method; Female; Fertilization in Vitro; Humans; Hypertension, Pregnancy | 2010 |
Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial.
Topics: Anticoagulants; Aspirin; Cohort Studies; Disease Progression; Enoxaparin; Female; Follow-Up Studies; | 2011 |
Chronotherapy with low-dose aspirin for prevention of complications in pregnancy.
Topics: Adult; Aspirin; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Double-Blind Method; Drug A | 2013 |
9 alpha,11 beta-prostaglandin F2 in pregnancies at high risk for hypertensive disorders of pregnancy, and the effect of acetylsalicylic acid.
Topics: Aspirin; Dinoprost; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complications, | 2003 |
Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.
Topics: Aspirin; Birth Weight; Enoxaparin; Female; Fetal Death; Folic Acid; Heparin, Low-Molecular-Weight; H | 2004 |
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Hype | 2004 |
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Hype | 2004 |
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Hype | 2004 |
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Hype | 2004 |
Low dose aspirin in women with raised maternal serum alpha-fetoprotein and abnormal Doppler waveform patterns from the uteroplacental circulation.
Topics: Adult; alpha-Fetoproteins; Aspirin; Female; Humans; Infant Mortality; Infant, Low Birth Weight; Infa | 1994 |
A study of use of low dose aspirin in prevention of pregnancy induced hypertension.
Topics: Aspirin; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy | 1994 |
Uterine Doppler in the identification of patients at risk for hypertension and IUGR.
Topics: Aspirin; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Hypertension; Infant, Newbor | 1994 |
Low-dose aspirin and hypertension in pregnancy.
Topics: Aspirin; Double-Blind Method; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Card | 1993 |
Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: a preliminary report.
Topics: Adult; Aspirin; Double-Blind Method; Embryonic and Fetal Development; Female; Humans; Hypertension; | 1994 |
Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin.
Topics: Adult; Aspirin; Double-Blind Method; Female; Fetal Blood; Humans; Hypertension; In Vitro Techniques; | 1994 |
Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn.
Topics: Adult; Aspirin; Drug Administration Schedule; Epoprostenol; Female; Humans; Hypertension; Pre-Eclamp | 1993 |
Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Topics: Abruptio Placentae; Adult; Aspirin; Double-Blind Method; Female; Humans; Hypertension; Incidence; Pa | 1993 |
Low-dose aspirin therapy to prevent preeclampsia.
Topics: Adult; Aspirin; Eclampsia; Female; Humans; Hypertension; Parity; Pre-Eclampsia; Pregnancy; Pregnancy | 1993 |
A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow.
Topics: Adult; Arteries; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pregna | 1996 |
Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Italian Study of Aspirin in Pregnancy Group.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Mass Index; Educational Status; Female | 1996 |
Platelet angiotensin II receptor status during pregnancy in Chinese women at high-risk of developing pregnancy-induced hypertension.
Topics: Adolescent; Adult; Angiotensin II; Aspirin; Blood Platelets; Calcium; Cohort Studies; Female; Food, | 1996 |
Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia.
Topics: Adult; Antihypertensive Agents; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Hum | 1997 |
Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Topics: Adult; Aspirin; Chronic Disease; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Humans; Hyp | 1998 |
In the dose range of 0.5-2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnancies.
Topics: Aspirin; Epoprostenol; Female; Humans; Hypertension; Platelet Aggregation Inhibitors; Pregnancy; Pre | 1999 |
Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension.
Topics: Analysis of Variance; Aspirin; Calcium; Chi-Square Distribution; Dietary Supplements; Female; Humans | 1999 |
Administration time-dependent effects of aspirin in women at differing risk for preeclampsia.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Pressure; Doubl | 1999 |
Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune D | 2001 |
Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches.
Topics: Adult; Arteries; Aspirin; Birth Weight; Blood Flow Velocity; Double-Blind Method; Female; Fetal Grow | 2002 |
Management and outcome of pregnancy in women with thrombophylic disorders and past cerebrovascular events.
Topics: Adult; Anticoagulants; Aspirin; Birth Weight; Cerebrovascular Disorders; Cohort Studies; Female; Fib | 2002 |
Low-dose aspirin in primigravidae with positive roll-over test.
Topics: Aspirin; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Infant, Newborn; Male; P | 1992 |
Hypertension in pregnancy.
Topics: Angiotensin II; Aspirin; Blood Flow Velocity; Female; Fetus; Humans; Hypertension; Placenta; Pre-Ecl | 1992 |
A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension.
Topics: Adult; Arachidonic Acid; Aspirin; Collagen; Female; Humans; Hypertension; Platelet Aggregation; Plat | 1992 |
Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension.
Topics: Administration, Oral; Adult; Aspirin; Blood Platelets; Drug Administration Schedule; Drug Evaluation | 1990 |
Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pregnan | 1990 |
The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies.
Topics: Adult; Aspirin; Clinical Trials as Topic; Double-Blind Method; Epoprostenol; Female; Humans; Hyperte | 1989 |
Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Blood Platelets; Epoprostenol; Female; Fetus; Humans; | 1989 |
Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae.
Topics: Adolescent; Adult; Angiotensin II; Aspirin; Blood Pressure; Clinical Trials as Topic; Double-Blind M | 1986 |
85 other studies available for aspirin and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Female; Humans; Postpartum | 2021 |
Improving Utilization of Aspirin for Prevention of Preeclampsia in a High-Risk Urban Cohort: A Prospective Cohort Study.
Topics: Adult; Aspirin; Cohort Studies; Drug Administration Schedule; Female; Gestational Age; Humans; Plate | 2021 |
[For a targeted use of aspirin].
Topics: Abnormalities, Drug-Induced; Antiphospholipid Syndrome; Aspirin; Female; Humans; Pre-Eclampsia; Preg | 2017 |
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.
Topics: Adult; Algorithms; Aspirin; Body Mass Index; Evidence-Based Medicine; Female; Gestational Age; Human | 2017 |
Acetylsalicylic acid in pregnant women with chronic hypertension.
Topics: Aspirin; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovasc | 2018 |
Chronic Hypertension in Pregnancy: New Concepts for Classification and Management.
Topics: Adult; Antihypertensive Agents; Aspirin; Chronic Disease; Female; Humans; Hypertension; Hypertension | 2019 |
Management of idiopathic recurrent pericarditis during pregnancy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Disease Management; Female; | 2019 |
Significant infrarenal aortic stenosis in pregnancy: a case report.
Topics: Adult; Aortic Valve Stenosis; Aspirin; Calcium; Calcium-Regulating Hormones and Agents; Cesarean Sec | 2019 |
Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy.
Topics: Adult; Antihypertensive Agents; Aspirin; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pre | 2013 |
Acute myocardial infarction in pregnancy following unlicensed use of methylenedioxymethamphetamine ('Ecstasy').
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Adult; Aspirin; Bisoprolol; Ch | 2013 |
[Thrombosis risk during pregnancy after history of cerebral venous thrombosis].
Topics: Adult; Anticoagulants; Aspirin; Chemoprevention; Family Health; Female; Humans; Intracranial Thrombo | 2015 |
Stroke prevention in women: synopsis of the 2014 American Heart Association/American Stroke Association guideline.
Topics: American Heart Association; Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Practice Guide | 2014 |
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Europe; Female; Heparin; Hu | 2014 |
The effect of calcium channel blockers on prevention of preeclampsia in pregnant women with chronic hypertension.
Topics: Adult; Amlodipine; Aspirin; Birth Weight; Blood Pressure; Calcium Channel Blockers; China; Female; H | 2015 |
[Mechanic valve prosthesis and pregnancy: Is Phenprocoumon replaceable?].
Topics: Abortion, Missed; Adult; Aortic Valve; Aspirin; Drug Substitution; Drug Therapy, Combination; Female | 2016 |
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Antibodies, Antiphospholipid; Antithrombin III Deficiency; Aspirin; Evidence-Based Medicine; Female; | 2008 |
Stroke in pregnancy associated with syphilis.
Topics: Adult; Anti-Bacterial Agents; Aspirin; Female; Gestational Age; Humans; Magnetic Resonance Imaging; | 2008 |
Acute myocardial infarction in pregnancy.
Topics: Adult; Angioplasty, Balloon, Coronary; Anticoagulants; Apgar Score; Aspirin; Cesarean Section; Coron | 2008 |
First trimester stroke prophylaxis in pregnant women with a history of stroke.
Topics: Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Health Care Surveys; Heparin, Low-Molecular-We | 2009 |
Medical treatment of pericarditis during pregnancy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination; Female; Glucocor | 2010 |
Livedoid vasculopathy and pregnancy.
Topics: Adult; Anticoagulants; Aspirin; Cicatrix; Dose-Response Relationship, Drug; Female; Humans; Pregnanc | 2009 |
Use of the Delphi method to facilitate antithrombotics prescription during pregnancy.
Topics: Anticoagulants; Aspirin; Delphi Technique; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; | 2010 |
Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option.
Topics: Anticoagulants; Aspirin; Female; Heart Valve Prosthesis; Heparin; Heparin, Low-Molecular-Weight; Hum | 2011 |
Susac syndrome and pregnancy: disease management.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Murine-Derived; Aspirin; Cyclophosphamide; D | 2011 |
[Peculiarities of pregnancy management after multiple stenting of coronary arteries].
Topics: Adult; Angioplasty, Balloon, Coronary; Aspirin; Cesarean Section; Coronary Vessels; Diagnosis, Diffe | 2012 |
Management of thrombosis during pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Antithrombins; Aspirin; Blood Coagulation Tests; Drug The | 2002 |
Management of ischaemic heart disease in women of child-bearing age.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Female; Fibrinolytic Agents; Humans; Hypoglycemic Agents; | 2004 |
Pregnancy after heart valve replacement--case report.
Topics: Adult; Anticoagulants; Aspirin; Cesarean Section; Female; Heart Valve Prosthesis; Heparin; Humans; M | 2004 |
[Strange pregnancy....].
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications, Cardiov | 2005 |
Thromboembolic disease and air travel in pregnancy: a survey of advice given by obstetricians.
Topics: Aircraft; Aspirin; Exercise; Female; Heparin; Humans; Leg; Movement; Obstetrics; Physician's Role; P | 2004 |
High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries.
Topics: Anemia; Anemia, Diamond-Blackfan; Aspirin; Data Collection; Female; France; Germany; Humans; Pregnan | 2006 |
Nationwide survey of pregnancy and delivery in patients with coronary arterial lesions caused by Kawasaki disease in Japan.
Topics: Adolescent; Adult; Aspirin; Cesarean Section; Coronary Artery Bypass; Coronary Disease; Coronary Ves | 2006 |
Low-molecular-weight heparin in pregnant women with prosthetic heart valves.
Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Aortic Valve; Aspirin; Biomarkers; Coronary Artery D | 2006 |
Atrial fibrillation in pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Aspirin; Atrial Fibrillation; Electrocardiography; Female; Flecainide | 2008 |
Pregnancy outcome in patients with patent foramen ovale and cerebral embolism.
Topics: Adult; Anticoagulants; Aspirin; Embolism, Paradoxical; Female; Foramen Ovale, Patent; Heparin, Low-M | 2008 |
[Case report of a successful pregnancy following thrombolysis for acute myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Anticoagulants; Aspirin; Electrocardiography; Female; Fibrinolyt | 2007 |
Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: a prospective cohort of 2736 women.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cohort Studies; Enoxaparin; Female | 2008 |
Acute thrombosis of a prosthetic mitral valve in pregnancy in spite of adjusted-dose low-molecular-weight heparin and aspirin.
Topics: Adult; Aspirin; Dose-Response Relationship, Drug; Echocardiography; Female; Fibrinolytic Agents; Fol | 2008 |
[Stents, antiplatelet therapy, and surgery].
Topics: Adult; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cesarean Section; Enoxaparin; Female | 2008 |
Drug-eluting stent implantation for acute myocardial infarction during pregnancy with use of glycoprotein IIb/IIIa inhibitor, aspirin and clopidogrel.
Topics: Aspirin; Clopidogrel; Coronary Angiography; Drug-Eluting Stents; Electrocardiography; Female; Humans | 2008 |
Lupus anticoagulant in pregnancy.
Topics: Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Chorea; Drug Therapy, Combination; | 1984 |
Pregnancy in 20 patients with bioprosthetic valve replacement.
Topics: Adult; Aortic Valve; Aspirin; Bioprosthesis; Female; Fetus; Heart Valve Prosthesis; Humans; Mitral V | 1983 |
[The course of pregnancy in patients with artificial valves].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Dipyridamole; Drug Therapy, Co | 1982 |
Pregnancy complicated by cerebral venous thrombosis in Behçet's disease.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Behcet Syndrome; Cerebral Veins; Female; Heparin; Humans; M | 1995 |
Conservative management of severe chronic hypertension in pregnancy.
Topics: Adult; Antihypertensive Agents; Aspirin; Chronic Disease; Female; Humans; Hypertension; Pregnancy; P | 1994 |
Pregnancy and prosthetic heart valves.
Topics: Abnormalities, Drug-Induced; Aspirin; Bioprosthesis; Embryo, Mammalian; Female; Heart Valve Prosthes | 1994 |
How Swedish obstetricians manage hypertensive disorders in pregnancy. A questionnaire study.
Topics: Adult; Antihypertensive Agents; Aspirin; Diuretics; Female; Humans; Hypertension; Pre-Eclampsia; Pre | 1994 |
Aspirin in pregnancy.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Hypertension; Parity; Pregnancy; Pregnancy Compli | 1993 |
Aspirin in pregnancy.
Topics: Aspirin; Bias; Female; Fetal Growth Retardation; Humans; Hypertension; Pregnancy; Pregnancy Complica | 1993 |
Low dose aspirin in pregnancy: a clinical and biochemical study of effects on the newborn.
Topics: Aspirin; Birth Weight; Cerebral Hemorrhage; Female; Fetal Blood; Fetal Growth Retardation; Gestation | 1993 |
Branch retinal artery occlusion in pregnancy.
Topics: Adult; Aspirin; Female; Headache; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Recurr | 1994 |
Effects of low-dose aspirin therapy on plasma levels of polyunsaturated fatty acids: a preliminary investigation.
Topics: Adult; Aspirin; Fatty Acids, Unsaturated; Female; Humans; Hypertension; Pilot Projects; Pre-Eclampsi | 1995 |
Low-dose aspirin therapy and placental pathology in women with poor prior pregnancy outcomes.
Topics: Adolescent; Adult; Aspirin; Drug Administration Schedule; Eclampsia; Female; Fetal Death; Humans; Pl | 1995 |
Perinatal morbidity in chronic hypertension.
Topics: Adult; Aspirin; Chronic Disease; Cohort Studies; Female; Fetal Death; Humans; Hypertension; Infant M | 1996 |
ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women.
Topics: Aspirin; Female; Fetal Diseases; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Compl | 1996 |
Multicentre trials in obstetrics and gynaecology. Smaller explanatory trials are required.
Topics: Aspirin; Female; Humans; Multicenter Studies as Topic; Pregnancy; Pregnancy Complications, Cardiovas | 1996 |
Primary stent implantation for acute myocardial infarction during pregnancy: use of abciximab, ticlopidine, and aspirin.
Topics: Abciximab; Adult; Antibodies, Monoclonal; Aspirin; Blood Vessel Prosthesis Implantation; Coronary An | 1998 |
Warfarin or aspirin: both or others?
Topics: Aged; Anticoagulants; Aspirin; Embolism; Female; Heart Diseases; Humans; Male; Middle Aged; Platelet | 1999 |
Safety of labor epidural anesthesia for women with severe hypertensive disease. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
Topics: Adult; Anesthesia, Epidural; Aspirin; Cesarean Section; Chronic Disease; Double-Blind Method; Female | 1999 |
High-risk pregnancy in beta-thalassemia major women. Report of three cases.
Topics: Adult; Aspirin; beta-Thalassemia; Cardiomyopathy, Dilated; Deferoxamine; Female; Humans; Pregnancy; | 2000 |
Essential thrombocythemia in young adults: major thrombotic complications and complications during pregnancy--a follow-up study in 68 patients.
Topics: Acute Disease; Adult; Age Factors; Arteriosclerosis; Aspirin; Busulfan; Cohort Studies; Disease-Free | 2000 |
[Myocardial infarction, pregnancy and anesthesia].
Topics: Adrenergic beta-Antagonists; Adult; Analgesia, Obstetrical; Analgesia, Patient-Controlled; Analgesic | 2000 |
Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications.
Topics: Abortion, Habitual; Aspirin; Female; Fetal Growth Retardation; Fetus; Heparin, Low-Molecular-Weight; | 2001 |
Late normalisation of uterine artery velocimetry in high risk pregnancy.
Topics: Arteries; Aspirin; Blood Flow Velocity; Dose-Response Relationship, Drug; Female; Fetal Death; Human | 2001 |
Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin.
Topics: Adult; Anticoagulants; Aspirin; Brain Infarction; Drug Therapy, Combination; Female; Heart Valve Pro | 2001 |
Non-pregnant circulatory volume status predicts subsequent pregnancy outcome in normotensive thrombophilic formerly preeclamptic women.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Folic Acid; Gestational Age; HELLP Syndrome | 2001 |
Enoxaparin treatment in women with mechanical heart valves during pregnancy.
Topics: Adult; Antibodies; Anticoagulants; Aspirin; Enoxaparin; Factor Xa; Female; Heart Valve Diseases; Hea | 2001 |
Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy.
Topics: Angiotensin II; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; In | 1978 |
[Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].
Topics: Adult; Anticoagulants; Aspirin; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Hum | 1975 |
Simultaneous vasculitis in a mother and newborn infant.
Topics: Adult; Arthritis; Aspirin; Female; Gangrene; Gentamicins; Heparin; Humans; Infant, Newborn; Infant, | 1975 |
Quadruplet pregnancy: contemporary management and outcome.
Topics: Adult; Aspirin; Bed Rest; Female; Humans; Hypertension; Infant, Newborn; Monitoring, Physiologic; Pr | 1992 |
Low-dose aspirin and vascular response in pregnant patients sensitive to angiotensin II.
Topics: Angiotensin II; Aspirin; Blood Pressure; Drug Interactions; Female; Humans; Hypertension; Pregnancy; | 1991 |
Prophylactic aspirin treatment: the merits of timing. International Womb-to-Tomb Chronome Study Group.
Topics: Aspirin; Circadian Rhythm; Female; Humans; Hypertension; Myocardial Infarction; Pilot Projects; Preg | 1991 |
Thromboxane A2 synthesis in pregnancy-induced hypertension.
Topics: Adolescent; Adult; Aspirin; Evaluation Studies as Topic; Female; Humans; Hypertension; Platelet Acti | 1990 |
Chronobiologic approach to pregnancy-induced hypertension and individualized assessment of low-dose aspirin for pre-eclampsia prevention.
Topics: Adult; Aspirin; Blood Pressure; Chronobiology Phenomena; Female; Heart Rate; Humans; Hypertension; P | 1990 |
Low-dose aspirin. II. Relationship of angiotensin II pressor responses, circulating eicosanoids, and pregnancy outcome.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Analysis of Variance; Angiotensin II; Aspirin; Bloo | 1990 |
Aspirin to prevent pregnancy-induced hypertension.
Topics: Aspirin; Female; Hemostasis; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascula | 1990 |
Prolongation of premature gestation in women with hemolysis, elevated liver enzymes and low platelets. A report of five cases.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Female; Hemolysis; Humans; Hypertension; Liver; Pregnancy; | 1990 |
[Prevention of complications of severe arterial hypertension in pregnancy using platelet antiaggregants].
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Hypertension; Pregnancy; Pr | 1989 |
Fibromuscular dysplasia of the carotid arteries complicating pregnancy.
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Female; Fibromuscular Dysplasi | 1989 |
Low-dose aspirin in pregnancy.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Hypertension; Infant, Newborn; Lupus Erythematosu | 1988 |
Mitral valve prolapse and thromboembolic disease in pregnancy: a case report.
Topics: Adult; Aspirin; Brain Ischemia; Contraceptives, Oral; Dipyridamole; Drug Therapy, Combination; Embol | 1988 |
Preeclampsia: platelets and antiplatelet therapy.
Topics: Aspirin; Blood Coagulation; Blood Platelets; Diagnosis, Differential; Female; Fetus; Humans; Hyperte | 1988 |
Low-dose aspirin. I. Effect on angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II.
Topics: Angiotensin II; Aspirin; Blood Pressure; Drug Administration Schedule; Drug Resistance; Female; Huma | 1988 |
Platelet function in pregnancy induced hypertension following treatment with labetalol and low dose aspirin.
Topics: Adenosine Diphosphate; Adult; Aspirin; Blood Platelets; Collagen; Dose-Response Relationship, Drug; | 1987 |